Multiple Myeloma Clinical Trials - Myeloma Clinical Trials

MMRC Clinical Trials

About the MMRC

The MMRC and its team of Principal Investigators are committed to excellence in multiple myeloma research by supporting, designing and implementing superior quality clinical trials with a mean time to clinical trial agreement that is 33% faster than industry comparison, study activation is 52% faster from final protocol compared to industry norms and 94% of MMRC trials achieve their accrual goals. These achievements surpass the industry norm while providing reliable and meaningful outcomes to advance the knowledge and options for treating patients with multiple myeloma.

Active Clinical Trials: 01/22/2018

The MMRC has conducted over 60 Phase I and II trials enrolling more than 1,500 patients to-date, providing invaluable insight into the successful conduct of multiple myeloma clinical trials. The major differentiating factors in working with MMRC for the conduct of Phase I and II trials in multiple myeloma are:

  • Streamlined communication—single point of contact who can leverage MMRC’s extensive MM Phase I/II clinical trial experience
  • MMRC is a recognized MM center of excellence for Phase I/II trials with focus on quality of trial conduct and data integrity, including renowned MM Key Opinion Leaders (KOL)
  • Leveraging a patient-driven collaborative research model that demonstrates faster trial starts and enrollment for MM Phase I/II trials

Current MMRC Trials

Are you a patient looking for a clinical trial? Join the Community Gateway.
When you join MMRF Community Gateway you’ll gain access to our clinical trial search tool which allows you to conduct customized searches for clinical trials. You can view, compare, and print trials and then discuss the best options with your doctor.